Fazeshift is an AI-native AR automation platform that replaces manual invoice-to-cash workflows with autonomous agents, purpose-built for traditional industries with deep integrations spanning staffing, services, wholesale, construction and beyond. The platform transforms traditionally time-consuming AR processes into streamlined, agentic operations, freeing finance teams from mundane, repetitive, and manual tasks, increasing efficiency and improving cash flow: lower DSO, reduced outstanding AR, and a direct impact on EBITDA.
Status: Private
Nava Therapeutics
Nava Therapeutics is a biotechnology company developing a new generation of genetic medicines through precision RNA delivery. By combining rational lipid design with high-throughput discovery, Nava has built a proprietary LNP platform capable of selectively targeting cells and tissues beyond the liver.
3F Labs
3F is a decentralized finance platform connecting top‑tier off-chain assets with on‑chain infrastructure. Built by DeFi pioneers, 3F provides global access to institutional‑grade yield opportunities through transparent, levered financial products. By bridging traditional asset classes with decentralized systems, 3F aims to unlock scalable, compliant, and efficient yield for a global audience.
Almanac Health
Almanac Health is a clinical AI platform that brings specialist-grade knowledge to clinicians at the point of care — providing evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. The platform integrates with existing EHR systems and is clinically validated through peer-reviewed research. Almanac Health was founded by Cyril Zakka, MD, author of one of NEJM AI’s most-cited papers on retrieval-augmented generation for clinical medicine.
Immutrin
Immutrin is a biotechnology company developing the next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis. The Company’s lead asset is being developed for the treatment of ATTR cardiomyopathy, a serious and progressive form of amyloidosis. Immutrin‘s antibody is a potential best-in-class therapy, with a unique mechanism of action designed to selectively and exclusively remove established amyloid fibrils.
Immutrin was co-founded by Cambridge Innovation Capital, academic founders Professor Sir Mark Pepys, FRS; Nobel Laureate Sir Gregory Winter, FRS; and Professor Daniel Christ and is built on decades of scientific and clinical leadership in amyloidosis combined with groundbreaking antibody expertise in drug development.
R1 Therapeutics
R1 Therapeutics is a clinical-stage biopharmaceutical company focusing on the development of first-in-class therapies for patients with kidney disease. Its lead program, AP306, targets hyperphosphatemia in patients with chronic kidney disease on dialysis, a condition associated with serious bone and cardiovascular complications and poorer outcomes when phosphate remains uncontrolled. AP306 is a first-in-class pan phosphate active transporter inhibitor with the potential to deliver rapid and effective phosphate lowering with a significantly reduced treatment burden. R1 is advancing AP306 in a global Phase 2b development program.
Cyclops
Cyclops is the first stablecoin and crypto infrastructure platform built exclusively for the payments industry. With low and no code solutions, Cyclops is the fastest way for payments companies to bring crypto and stablecoin offerings to market. Founded by crypto and payments industry veterans who built crypto solutions for Shift4, Cyclops enables crypto acceptance, stablecoin settlement and stablecoin payouts for payments companies.
STS Digital
STS Digital is a regulated principal trading firm specialized in digital-asset derivatives and providing institutional-grade market access. Clients can trade more than 400 tokens across vanilla and exotic options, spot, and structured products through a unified platform spanning UI, API, and voice channels. Built by derivatives veterans and licensed by the Bermuda Monetary Authority, STS Digital delivers deep liquidity, competitive pricing, and robust risk-management to ensure a seamless trading experience.
Jump
Jump is an AI assistant for wealth management, enabling financial advisors to automate workflows prior to, during, and after client-facing meetings. Using Jump, advisors can save up to 20 hours per week by automating administrative tasks like meeting prep, note-taking, and email follow-up.
Monark Markets
Monark Markets provides “Alts-As-A-Service” infrastructure to brokerage firms and wealth management platforms. Monark’s APIs enable embedded access to private markets from within partners’ existing trading platforms.